We are monitoring the impact of COVID-19 on Europe Protein Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 5063
Share on
Share on

Europe Protein Therapeutics Market Research Report - Segmented By Product, By Application, By Therapeutic Modalities & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019-2024)

Pulished: August, 2019
ID: 5063
Pages: 145

Europe Protein Therapeutics Market Size & Growth (2019 - 2024)

As per the research report, the size of the Europe Protein Therapeutics market size is valued at USD 39.98 billion in 2019. It is expected to grow at a CAGR of 6.3% to reach USD 54.27 billion by 2024 during the forecast period 2019-2024. It captures 25% of the global market.

Protein therapeutics is most often employed in the treatment of chronic ailments like cancer etc. This market has a huge potential in the coming years.

Increasing number of people suffering from chronic diseases coupled with rapid advancements in the medical sciences resulting in the development of plasma based therapies are driving the growth of this market.

On the other hand, vague government policies and cumbersome administrative framework conjoined with the heavy cost of this treatment are inhibiting market growth.

This research report segmented and sub-segmented into the following categories:

  • By Product: Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone
  • By Application: Metabolic Disorders, Immunologic Disorders, Haematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Others
  • By Therapeutic Modalities: Protein Diagnostics, Protein Vaccines, Protein Therapeutics With Special Targeting Activity, Protein Therapeutics With Enzymatic Or Regulatory Activity
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

In 2016, Monoclonal antibodies captured the largest market share. It is projected to remain the top leading segment in the forecast period. It is also the market sub-segment which is anticipated to undergo fastest growth till 2022. However, cancer market sub-category is predicted to grow the fastest in the forecast period. It is the second largest market lead by UK.

Key players operating in the Europe Protein Therapeutics Market profiled in this report are Baxter International Inc., Eli Lilly and Company, Abbott Laboratories, Amgen Inc., F. Hoffmann-La Roche Ltd. Other players in the market are Novo Nordisk A/S, Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., and Sanofi.

1. Introduction       

               1.1 Market Definition                    

               1.2 Study Deliverables                  

               1.3 Base Currency, Base Year and Forecast Periods 

               1.4 General Study Assumptions                 

2. Research Methodology                 

               2.1 Introduction    

               2.2 Research Phases                      

     2.2.1 Secondary Research           

     2.2.2 Primary Research 

     2.2.3 Econometric Modelling      

     2.2.4 Expert Validation  

               2.3 Analysis Design                        

               2.4 Study Timeline

3. Overview            

               3.1 Executive Summary                

               3.2 Key Inferences

               3.3 Epidemology   

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

               4.1 Market Drivers

               4.2 Market Restraints                   

               4.3 Key Challenges

               4.4 Current Opportunities in the Market               

5. Market Segmentation                   

               5.1 Product                       

     5.1.1 Introduction           

     5.1.2 Monoclonal Antibodies      

     5.1.3 Insulin       

     5.1.4 Fusion Protein       

     5.1.5 Erythropoietin       

     5.1.6 Interferon

     5.1.7 Human Growth Hormone  

     5.1.8 Follicle Stimulating Hormone          

     5.1.9 Y-o-Y Growth Analysis, By Product

     5.1.10 Market Attractiveness Analysis, By Product           

     5.1.11 Market Share Analysis, By Product            

               5.2 Therapeutic Modalities

     5.2.1 Introduction           

     5.2.2 Protein diagnostics             

     5.2.3 Protein vaccines   

     5.2.4 Protein therapeutics with special targeting activity

     5.2.5 Protein therapeutics with enzymatic or regulatory activity 

     5.2.6 Y-o-Y Growth Analysis, By Therapeutic Modalities  

     5.2.7 Market Attractiveness Analysis, By Therapeutic Modalities

     5.2.8 Market Share Analysis, By Therapeutic Modalities

               5.3 Application                 

     5.3.1 Introduction           

     5.3.2 Metabolic Disorders            

     5.3.3 Immunologic Disorders      

     5.3.4 Hematological Disorders    

     5.3.5 Cancer      

     5.3.6 Hormonal Disorders            

     5.3.7 Genetic Disorders 

     5.3.8 Others      

     5.3.9 Y-o-Y Growth Analysis, By Application         

     5.3.10 Market Attractiveness Analysis, By Application     

     5.3.11 Market Share Analysis, By Application      

6. Geographical Analysis                   

               6.1 Introduction    

     6.1.1 Regional Trends    

     6.1.2 Impact Analysis     

     6.1.3 Y-o-Y Growth Analysis        

                    6.1.3.1 By Geographical Area

                    6.1.3.2 By Product

                    6.1.3.3 By Therapeutic Modalities

                    6.1.3.4 By Application

     6.1.4  Market Attractiveness Analysis      

                    6.1.4.1 By Geographical Area

                    6.1.4.2 By Product

                    6.1.4.3 By Therapeutic Modalities

                    6.1.4.4 By Application

     6.1.5  Market Share Analysis       

                    6.1.5.1 By Geographical Area

                    6.1.5.2 By Product

                    6.1.5.3 By Therapeutic Modalities

                    6.1.5.4 By Application

               6.2 U.K                

               6.3 Spain  

               6.4 Germany                     

               6.5 Italy    

               6.6 France

7. Strategic Analysis             

               7.1 PESTLE analysis                        

     7.1.1 Political    

     7.1.2 Economic 

     7.1.3 Social        

     7.1.4 Technological        

     7.1.5 Legal         

     7.1.6 Environmental       

               7.2 Porter’s Five analysis    

     7.2.1 Bargaining Power of Suppliers         

     7.2.2 Bargaining Power of Consumers     

     7.2.3 Threat of New Entrants      

     7.2.4 Threat of Substitute Products and Services

     7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis              

               8.1 Abbott Laboratories               

     8.1.1 Overview 

     8.1.2 Product Analysis   

     8.1.3 Financial analysis  

     8.1.4 Recent Developments        

     8.1.5 SWOT analysis       

     8.1.6 Analyst View          

               8.2 Amgen Inc.                

               8.3 Baxter International Inc.                      

               8.4 Eli Lilly and Company   

               8.5 F. Hoffmann-La Roche Ltd.                  

               8.6 Johnson & Johnson                

               8.7 Merck & Co. Inc.                     

               8.8 Novo Nordisk A/S                    

               8.9 Pfizer Inc.                   

               8.10 Sanofi                       

9. Competitive Landscape                

               9.1 Market share analysis  

               9.2 Merger and Acquisition Analysis                       

               9.3 Agreements, collaborations and Joint Ventures 

               9.4 New Product Launches

10. Market Outlook and Investment Opportunities                

Appendix                 

               a) List of Tables                

               b) List of Figures    

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Protein Therapeutics Market By Product, From 2019-2024 ( USD Billion )
  2. Europe Monoclonal Antibodies Market By Region, From 2019-2024 ( USD Billion )
  3. Europe Insulin Market By Region, From 2019-2024 ( USD Billion )
  4. Europe Fusion Protein Market By Region, From 2019-2024 ( USD Billion )
  5. Europe Erythropoietin Market By Region, From 2019-2024 ( USD Billion )
  6. Europe Interferon Market By Region, From 2019-2024 ( USD Billion )
  7. Europe Human Growth Hormone Market By Region, From 2019-2024 ( USD Billion )
  8. Europe Follicle Stimulating Hormone Market By Region, From 2019-2024 ( USD Billion )
  9. Europe Protein Therapeutics Market By Application, From 2019-2024 ( USD Billion )
  10. Europe Metabolic Disorders Market By Region, From 2019-2024 ( USD Billion )
  11. Europe Immunologic Disorders Market By Region, From 2019-2024 ( USD Billion )
  12. Europe Hematological Disorders Market By Region, From 2019-2024 ( USD Billion )
  13. Europe Cancer Market By Region, From 2019-2024 ( USD Billion )
  14. Europe Hormonal Disorders Market By Region, From 2019-2024 ( USD Billion )
  15. Europe Genetic Disorders Market By Region, From 2019-2024 ( USD Billion )
  16. Europe Others Market By Region, From 2019-2024 ( USD Billion )
  17. Europe Protein Therapeutics Market By Therapeuctic Modalities, From 2019-2024 ( USD Billion )
  18. Europe Protein diagnostics Market By Region, From 2019-2024 ( USD Billion )
  19. Europe Protein vaccines Market By Region, From 2019-2024 ( USD Billion )
  20. Europe Protein therapeutics with special targeting activity Market By Region, From 2019-2024 ( USD Billion )
  21. Europe Protein therapeutics with enzymatic or regulatory activity Market By Region, From 2019-2024 ( USD Billion )
  22. U.K. Protein Therapeutics Market By Product, From 2019-2024 ( USD Billion )
  23. U.K. Protein Therapeutics Market By Application, From 2019-2024 ( USD Billion )
  24. U.K. Protein Therapeutics Market By Therapeuctic Modalities, From 2019-2024 ( USD Billion )
  25. Germany Protein Therapeutics Market By Product, From 2019-2024 ( USD Billion )
  26. Germany Protein Therapeutics Market By Application, From 2019-2024 ( USD Billion )
  27. Germany Protein Therapeutics Market By Therapeuctic Modalities, From 2019-2024 ( USD Billion )
  28. France Protein Therapeutics Market By Product, From 2019-2024 ( USD Billion )
  29. France Protein Therapeutics Market By Application, From 2019-2024 ( USD Billion )
  30. France Protein Therapeutics Market By Therapeuctic Modalities, From 2019-2024 ( USD Billion )
  31. Italy Protein Therapeutics Market By Product, From 2019-2024 ( USD Billion )
  32. Italy Protein Therapeutics Market By Application, From 2019-2024 ( USD Billion )
  33. Italy Protein Therapeutics Market By Therapeuctic Modalities, From 2019-2024 ( USD Billion )
  34. Spain Protein Therapeutics Market By Product, From 2019-2024 ( USD Billion )
  35. Spain Protein Therapeutics Market By Application, From 2019-2024 ( USD Billion )
  36. Spain Protein Therapeutics Market By Therapeuctic Modalities, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample